CannaEvidence
Is this for me?
Is this for me?

Europe · all countries · model C — Product-, indication- or hospital-gated

Medical cannabis in Cyprus

Legal framework since 2019, supply unverified

Cyprus has had a medical-cannabis framework since March 2019 — dried cannabis and pharmacy-made preparations from up to three state-licensed producers, dispensed by pharmacies on a doctor's prescription — but no official page reachable in this session confirms that a licensed product is actually on sale or how a new patient obtains one today.

The hardest fact about Cyprus. Driving is the hard line: Cyprus road law treats any laboratory-detected controlled substance 'ανεξάρτητα από την ποσότητα' (regardless of quantity) as proof of drug-driving, with no exemption for prescribed cannabis, up to 3 years' prison and €8,000.

Every answer below was read in the law, the register or the official statistic itself. This country is part of the Europe layer: an English page of verified facts, no directory. Where an answer is marked as not published, no official source states it — we did not fill the gap with a guess.

The questions, answered for Cyprus

How access works here

The one-line answer: can a new patient start today, and through what.

C — licensed-product and prescription gated. The Ο περί Ναρκωτικών Φαρμάκων και Ψυχοτρόπων Ουσιών Νόμος (Narcotic Drugs and Psychotropic Substances Law, 29/1977) as amended by Ν. 10(Ι)/2019, with the Κ.Δ.Π. 73/2019 regulations, allows up to three licensed producers to grow, produce and import 'φαρμακευτική κάνναβη' (medical cannabis) for supply to pharmacies, and lets a patient lawfully possess cannabis obtained from a pharmacy on a doctor's prescription.

Κ.Δ.Π. 73/2019 'Οι περί Ναρκωτικών Φαρμάκων και Ψυχοτρόπων Ουσιών (Φαρμακευτική Κάνναβη) Κανονισμοί του 2019' (published 6 March 2019): Reg. 2(1) defines φαρμακευτική κάνναβη as cannabis cultivated, produced, imported, exported, prescribed and supplied to patients 'για την αντιμετώπιση ιατρικών παθήσεων'; Reg. 6(4) caps producer licences at three within a 15-year exclusivity period; Reg. 6(3) selects licensees by 'Πρόσκληση για εκδήλωση ενδιαφέροντος' (call for expressions of interest, €5,000 fee) through a selection committee; the Υπουργός Υγείας (Minister of Health) grants licences (Reg. 21); Reg. 6(2) lets the competent authority import while local production is pending; Reg. 5(5) requires GMP-equivalent certification for imported dry cannabis. Ν. 10(Ι)/2019 amended arts. 7, 7A, 8, 11, 24 and added art. 28A of the basic law to enable licensing regulations, inspectors and administrative fines up to €25,000. No later amendment of the cannabis regulations appears in the 2020–2026 Κ.Δ.Π. indexes.

Source: Κ.Δ.Π. 73/2019 — Οι περί Ναρκωτικών Φαρμάκων και Ψυχοτρόπων Ουσιών (Φαρμακευτική Κάνναβη) Κανονισμοί του 2019 (Medical Cannabis Regulations 2019), CyLaw · read 27 September 2026

What may be prescribed

What the law allows a doctor to write on a prescription here.

The regulations cover 'ξηρή κάνναβη' (dried cannabis) packed for medical use and 'γαληνικά σκευάσματα' (pharmacy-made galenic preparations) containing medical cannabis; the permitted types and quantity limits are set in Regs. 92–93 and the Third Annex, whose text could not be read. No official list of products actually available was found.

Reg. 2(1) and Reg. 5(1)(a): production runs from harvest to packaging and labelling of dried cannabis in immediate containers for medical use, for galenic preparation in pharmacies, or for manufacture of medicinal products. The table of contents lists Reg. 92 'Είδος κάνναβης' (type of cannabis), Reg. 93 'Καθορισμός ποσοτικών ορίων' (quantity limits), Reg. 94 'Συνταγογράφηση και χρήση γαληνικών σκευασμάτων', Reg. 95 'Απαγόρευση συνταγογράφησης' (prohibition on prescribing), Reg. 96 'Έκδοση γαληνικών σκευασμάτων'. Authorised cannabinoid medicines (Sativex, Epidyolex) fall under the ordinary medicines law, not these regulations.

Source: Κ.Δ.Π. 73/2019 (Medical Cannabis Regulations 2019), CyLaw · read 27 September 2026

Who may prescribe

Whether you need a specialist, and whether anyone has to approve it first.

Not published

A registered doctor ('ιατρός' under the Medical Registration Law) may prescribe under the regulations, but whether specialties, listed conditions or a prior-approval step apply (Regs. 94–95, Third Annex) could not be verified because the regulation text was truncated in this session.

Reg. 2(1) defines the prescriber by reference to registration under the Ο περί Εγγραφής Ιατρών Νόμος; Reg. 4(2)(a) authorises possession by a person who obtained cannabis from a pharmacy 'με βάση συνταγή που εκδόθηκε από ιατρό'. Reg. 95 is titled 'Απαγόρευση συνταγογράφησης', implying restrictions, but its content is not published in any page opened. The Ministry of Health / Pharmaceutical Services website (moh.gov.cy) is closed to automated fetching (robots.txt).

Source: Κ.Δ.Π. 73/2019 (Medical Cannabis Regulations 2019), CyLaw · read 27 September 2026

Type of prescription

The form itself: which prescription, how long it is valid, how much it covers.

A controlled-drug prescription under the narcotics regulations; since 2019 these accept electronic prescriptions, with software retrieval counting as proof of authenticity. Cannabis-specific validity and quantity limits (Reg. 93) were not readable.

Κ.Δ.Π. 160/2019 amended the general Narcotic Drugs and Psychotropic Substances Regulations (Regs. 11, 12, 16) to allow 'ηλεκτρονικές συνταγές': handwriting/ink-signature requirements are waived and 'θεωρείται ως επαρκές τεκμήριο αυθεντικότητας της συνταγής το γεγονός ότι αυτή ανακτήθηκε μέσω του κατάλληλου λογισμικού'; electronic registers are permitted. Entry into force was notified by Κ.Δ.Π. 34/2020 (Gazette 31 January 2020). Cannabis quantity limits sit in Reg. 93 of Κ.Δ.Π. 73/2019 (text not read).

Source: Κ.Δ.Π. 160/2019 — Οι περί Ναρκωτικών Φαρμάκων και Ψυχοτρόπων Ουσιών (Τροποποιητικοί) Κανονισμοί του 2019 (electronic prescriptions), CyLaw · read 27 September 2026

Telemedicine

Whether a prescription can lawfully begin in a video call.

Not published

Not published. No official Cypriot text opened addresses whether a cannabis prescription may be issued after a video consultation; the narcotics regulations allow electronic prescriptions but say nothing about the consultation itself.

Κ.Δ.Π. 160/2019 concerns the form of the prescription only. Κ.Δ.Π. 73/2019 Regs. 94–95 (prescribing rules) could not be read. The Ministry of Health site is unreachable for automated checks.

Source: Κ.Δ.Π. 160/2019 (electronic prescriptions), CyLaw · read 27 September 2026

Dispensing

Which pharmacy can actually hand it over.

Pharmacies dispense on prescription; licensed producers must hold a wholesale licence to supply them. Whether public (state) or private pharmacies are involved, and whether any pharmacy currently stocks licensed cannabis, is not published on pages opened.

Reg. 5(1)(a) and 5(7): producers supply 'στα φαρμακεία' and need a wholesale distribution licence under art. 83 of the Medicines Law; Reg. 4(2)(a): lawful patient possession requires supply 'από φαρμακείο'. No mail-order or delivery provision was seen.

Source: Κ.Δ.Π. 73/2019 (Medical Cannabis Regulations 2019), CyLaw · read 27 September 2026

Reimbursement

Whether anyone other than you pays for it.

Not published

Not published. Neither the 2019 regulations nor any reachable official page states whether ΓεΣΥ (the General Healthcare System) covers medical cannabis.

Κ.Δ.Π. 73/2019 contains no pricing or reimbursement provisions in the parts read. The ΓεΣΥ/ΟΑΥ and Ministry of Health websites could not be fetched. Treat as self-pay until an official source says otherwise.

Source: Κ.Δ.Π. 73/2019 (Medical Cannabis Regulations 2019), CyLaw · read 27 September 2026

What it costs

What you pay, as far as anyone publishes it.

Not published

No public price. No official Cypriot price list for medical cannabis exists on any page opened.

The regulations set no prices; the Pharmaceutical Services' price lists could not be accessed (site blocks automated fetching).

Source: Κ.Δ.Π. 73/2019 (Medical Cannabis Regulations 2019), CyLaw · read 27 September 2026

Driving

The question with the worst consequences and the least reliable information online.

Zero tolerance: driving 'υπό την επήρεια ναρκωτικών' is an offence, and the law says a laboratory finding of any controlled substance 'ανεξάρτητα από την ποσότητα' is the proof; there is no written exemption for prescribed cannabis. Penalties reach 3 years' imprisonment, €8,000 and licence disqualification.

Ο περί Οδικής Ασφάλειας Νόμος (Road Safety Law, 174/1986), Part IIIA inserted by Ν. 13(Ι)/2016: art. 11Β 'Πρόσωπο το οποίο οδηγεί ή αποπειράται να οδηγήσει οποιοδήποτε όχημα … ενώ τελεί υπό την επήρεια ναρκωτικών, διαπράττει αδίκημα'; art. 11Α defines ναρκωτικά as controlled substances under the Narcotic Drugs and Psychotropic Substances Laws (which include cannabis/THC); art. 11Ε: 'λαμβάνονται υπόψη μόνο τα αποτελέσματα της εργαστηριακής εξέτασης, δεδομένου ότι σε αυτά έχουν εντοπιστεί ναρκωτικά ανεξάρτητα από την ποσότητα'; art. 11Ζ(1): imprisonment up to 3 years or fine up to €8,000 or disqualification. Art. 11Γ(7) gives a medical ground only for refusing a sample, not a defence to the offence.

Source: Ο περί Οδικής Ασφάλειας Νόμος (Road Safety Law 174/1986), art. 11Α–11Ζ, CyLaw consolidated text · read 27 September 2026

Travel

Taking it across a border, which is where most published advice is simply wrong.

Not published

Cyprus is outside Schengen, so the Article 75 certificate does not apply; the national rule for travellers carrying prescribed cannabis in or out (permit, quantity, days) is published by the Pharmaceutical Services, whose website could not be opened in this session.

The Narcotic Drugs and Psychotropic Substances Law prohibits import of cannabis without licence (arts. 4–7); Κ.Δ.Π. 73/2019 allows import only by licensed producers or the competent authority (Regs. 5, 6(2)). No personal-import exemption for travellers was seen in the texts read; the Ministry of Health/Pharmaceutical Services pages (moh.gov.cy) are blocked by robots.txt. Not published here.

Source: Ο περί Ναρκωτικών Φαρμάκων και Ψυχοτρόπων Ουσιών Νόμος (Narcotic Drugs and Psychotropic Substances Law 29/1977), CyLaw consolidated text · read 27 September 2026

As a visitor or new resident

Four things nobody publishes together: getting a prescription as a non-resident, using a prescription from another EU country, bringing your own medicine in, and whether a foreign video consultation counts.

The 2019 regulations impose no residency test on the patient, but a foreign cannabis prescription is not dispensable under Cypriot narcotics rules as far as published, and Cyprus (non-Schengen) publishes its traveller rule only on a Ministry site that could not be reached.

(1) Non-resident prescription: Κ.Δ.Π. 73/2019 defines the patient by treatment need, not residency; the practical gate (prescriber restrictions in Regs. 94–95, e-prescription identity) is not published in pages opened. (2) Foreign EU prescription: Cyprus transposed Directive 2011/24/EU by Ν. 149(Ι)/2013 'περί της Εφαρμογής των Δικαιωμάτων των Ασθενών στο πλαίσιο της Διασυνοριακής Υγειονομικής Περίθαλψης'; art. 8(3) refers prescription elements to Annex III of the Pharmacy and Poisons Law, but no article excluding narcotic prescriptions (Art. 11(6)) was found in the text read — not published. (3) Bringing medicine in: non-Schengen; national rule not published on pages opened (see travel). (4) Foreign telemedicine prescription: not published; follows (2).

Source: Ν. 149(Ι)/2013 — περί της Εφαρμογής των Δικαιωμάτων των Ασθενών στο πλαίσιο της Διασυνοριακής Υγειονομικής Περίθαλψης Νόμος (Cross-Border Healthcare Law), CyLaw · read 27 September 2026

What is changing

What is pending in parliament or at the regulator, with dates — or the statement that nothing is.

Not published

No amendment to the 2019 medical-cannabis regulations appears in the official regulatory-acts indexes for 2020–2026; whether the licensing tender has produced an operating producer, and any pending reform, is not published on pages opened.

CyLaw's Κ.Δ.Π. indexes for 2020–2026 list only general controlled-drug orders (e.g. Κ.Δ.Π. 42/2024, 134/2024, 22/2025 under art. 29(1)) and none amending Κ.Δ.Π. 73/2019. The Road Safety Law was last amended by Ν. 103(Ι)/2026 (content not checked). Ministry of Health announcements could not be fetched.

Source: CyLaw — Κανονιστικές Διοικητικές Πράξεις 2025 index (regulatory acts index) · read 27 September 2026

Number of patients

How many people this actually concerns — where anyone counts.

Not published

No official count of Cypriot medical-cannabis patients or prescriptions was found; the Ministry of Health site could not be opened.

The regulations create record-keeping duties for producers and pharmacies but no published statistics were located.

Source: Κ.Δ.Π. 73/2019 (Medical Cannabis Regulations 2019), CyLaw · read 27 September 2026

What we can publish for Cyprus, and what we cannot

Four directories, four honest answers. Where an official register exists we republish it and link every entry back to the source. Where none exists, that is what the page says — a list built out of self-declarations would be worse than no list, and saying so is more useful to you than pretending.

Doctors

No list — by design

Prescribers are registered doctors under the Medical Registration Law; no state list of cannabis prescribers exists and the general register does not identify them.

Pharmacies

No list — by design

Any pharmacy may dispense on prescription; no official register marks pharmacies that stock medical cannabis.

Products and preparations

No list — by design

No official list of licensed medical-cannabis products or licensed producers was reachable; the regulations foresee producer licences but publish no product register.

Telemedicine platforms

No list — by design

No official telehealth route; the regulations do not address remote consultations and no regulator page was reachable.

Where this country's law lives

Everything above comes from these texts rather than from another portal's summary. They are listed so you can check us.

Crossing a border with this

Two European rules decide most of what a traveller asks. Directive 2011/24/EU obliges pharmacies to honour prescriptions from another Member State — but only for medicines authorised in the dispensing country, and its Article 11(6) says the rule “shall not apply to medicinal products subject to special medical prescription”, which is where narcotic prescriptions sit. A magistral cannabis preparation is neither authorised nor outside that exclusion, so a cannabis prescription from another country is, as a rule, not dispensable anywhere in Europe. For carrying your own medicine, Article 75 of the Schengen Convention lets a resident of a Schengen state travel with a certified supply for up to 30 days; outside Schengen, national import rules apply. The country-specific answer is above under “As a visitor or new resident”.

Directive 2011/24/EU, Article 11(1) and 11(6) — read on EUR-Lex on 27 September 2026: CELEX 32011L0024.

Other countries with the same model (product-, indication- or hospital-gated)

The answers change at every border, and a prescription does not travel with you. Compare before you assume.